 |
|
Revised ACIP Recommendation for Avoiding Pregnancy After Receiving a Rubella-Containing Vaccine
JAMA. 2002;287:311-312.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
MMWR. 2001;50:1117
On October 18, 2001, the Advisory Committee on Immunization Practices (ACIP) reviewed data from several sources indicating that no cases of congenital rubella syndrome (CRS) had been identified among infants born to women who were vaccinated inadvertently against rubella within 3 months or early in pregnancy. On the basis of these data, ACIP shortened its recommended period to avoid pregnancy after receipt of rubella-containing vaccine from 3 months to 28 days.
Data were available from the U.S. Rubella Vaccine in Pregnancy Registry,1 the U.K. National Congenital Rubella Surveillance Programme (National Congenital Registry Surveillance Programme, unpublished data, 2001; P. Tookey, Ph.D., Center of Paediatric Epidemiology and Biostatistics, Institute of Child Health, London, personal communication, April 2001), and Sweden and Germany (G. Enders, M.D., Laboratory of Enders and Partners, and Institute for Virology, Infectology, and Epidemiology, personal communication, September 2001) on 680 live births to susceptible women who were inadvertently . . . [Full Text of this Article]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Mechanism of Action at the Molecular Level of the Antiviral Drug 3(2H)-Isoflavene against Type 2 Poliovirus
Salvati et al.
Antimicrob. Agents Chemother. 2004;48:2233-2243.
ABSTRACT
| FULL TEXT
Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia
Blomqvist et al.
J. Virol. 2004;78:4876-4883.
ABSTRACT
| FULL TEXT
Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis
Buttinelli et al.
J. Gen. Virol. 2003;84:1215-1221.
ABSTRACT
| FULL TEXT
|
